A detailed history of Invesco Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Invesco Ltd. holds 241,594 shares of EXAS stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
241,594
Previous 243,465 0.77%
Holding current value
$13.9 Million
Previous $10.3 Million 59.93%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$42.43 - $70.83 $79,386 - $132,522
-1,871 Reduced 0.77%
241,594 $16.5 Million
Q2 2024

Aug 13, 2024

SELL
$41.33 - $74.26 $901,779 - $1.62 Million
-21,819 Reduced 8.22%
243,465 $10.3 Million
Q1 2024

May 14, 2024

SELL
$56.27 - $73.77 $108 Million - $142 Million
-1,926,292 Reduced 87.9%
265,284 $18.3 Million
Q4 2023

Feb 12, 2024

BUY
$59.06 - $75.72 $696,258 - $892,663
11,789 Added 0.54%
2,191,576 $162 Million
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $53.6 Million - $80.5 Million
-813,055 Reduced 27.17%
2,179,787 $149 Million
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $49.5 Million - $75.1 Million
790,334 Added 35.88%
2,992,842 $281 Million
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $8.8 Million - $13.2 Million
186,498 Added 9.25%
2,202,508 $149 Million
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $188,200 - $329,583
6,201 Added 0.31%
2,016,010 $99.8 Million
Q3 2022

Nov 14, 2022

SELL
$31.97 - $49.37 $251,412 - $388,245
-7,864 Reduced 0.39%
2,009,809 $65.3 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $1.41 Million - $3.02 Million
39,682 Added 2.01%
2,017,673 $79.5 Million
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $1.79 Million - $2.56 Million
31,061 Added 1.6%
1,977,991 $138 Million
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $35,960 - $49,937
-496 Reduced 0.03%
1,946,930 $152 Million
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $7.99 Million - $11 Million
-88,575 Reduced 4.35%
1,947,426 $186 Million
Q2 2021

Aug 17, 2021

SELL
$93.66 - $139.27 $1.69 Million - $2.52 Million
-18,060 Reduced 0.88%
2,036,001 $253 Million
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $28.2 Million - $37.5 Million
-241,845 Reduced 10.53%
2,054,061 $271 Million
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $52.4 Million - $74.8 Million
-526,460 Reduced 18.65%
2,295,906 $304 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $300,649 - $420,587
-4,123 Reduced 0.15%
2,822,366 $288 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $6,913 - $11,501
124 Added 0.0%
2,826,489 $246 Million
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $372,443 - $1.03 Million
9,827 Added 0.35%
2,826,365 $164 Million
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $25.9 Million - $33.3 Million
-333,769 Reduced 10.59%
2,816,538 $260 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $657,983 - $891,849
7,281 Added 0.23%
3,150,307 $285 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $236 Million - $311 Million
2,634,078 Added 517.55%
3,143,026 $371 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $2.29 Million - $3.57 Million
-37,021 Reduced 6.78%
508,948 $44.1 Million
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $30.6 Million - $45.1 Million
545,969 New
545,969 $34.5 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.